Integrin αvβ6-targeted SPECT imaging for pancreatic cancer detection

Journal of Nuclear Medicine

Volumn 55, Issue 6, 2014, Pages 989-994

  Liu, Zhaofei ^a,b   Liu, Hao ^a,b   Ma, Teng ^a,b   Sun, Xianlei ^a,b   Shi, Jiyun ^a   Jia, Bing ^a,b   Sun, Yi ^c   Zhan, Jun ^b,d   Zhang, Hongquan ^b,d   Zhu, Zhaohui ^c   Wang, Fan ^a,b,e  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^e INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Molecular imaging; Pancreatic cancer; Phage display; SPECT CT

Indexed keywords

ALPHAVBETA6 INTEGRIN; TECHNETIUM 6 HYDRAZINONICOTINYL HK PEPTIDE TC 99M; TRACER; UNCLASSIFIED DRUG; INTEGRIN; PEPTIDE; TECHNETIUM; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG DISTRIBUTION; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LIVER METASTASIS; LIVER PARENCHYMA; MOUSE; NONHUMAN; PANCREAS CANCER; PANCREATOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIOCHEMISTRY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; DRUG DESIGN; GENE EXPRESSION REGULATION; METABOLISM; MOLECULAR GENETICS; PANCREAS TUMOR; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; DRUG DESIGN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; MICE; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY; TECHNETIUM; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84903220832     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.132969     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2. Mendieta Zerón H, Garcia Flores JR, Romero Prieto ML. Limitations in improving detection of pancreatic adenocarcinoma. Future Oncol. 2009;5:657-668.
3. 6 in cancer. Curr Drug Targets. 2009;10:645-652.
4. Sipos B, Hahn D, Carceller A, et al. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology. 2004;45:226-236. (Pubitemid 39279179)
5. Bates RC, Bellovin DI, Brown C, et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest. 2005;115:339-347. (Pubitemid 40385475)
6. 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J Pathol. 2007;212:316-324.
7. 6 expression with positron emission tomography. Cancer Res. 2007;67:7833-7840.
8. 6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res. 2009;69:5843-5850.
9. Kimura RH, Teed R, Hackel BJ, et al. Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer. Clin Cancer Res. 2012;18:839-849.
10. 6. J Nucl Med. 2013;54:1101-1105.
11. Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Copper chelation chemistry and its role in copper radiopharmaceuticals. Curr Pharm Des. 2007;13:3-16. (Pubitemid 46085298)
12. 99mTc-3PRGD2 in non-human primates. Mol Imaging Biol. 2011;13:730-736.
13. Oyama T, Sykes KF, Samli KN, Minna JD, Johnston SA, Brown KC. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett. 2003;202:219-230. (Pubitemid 37485895)
14. Zhou X, Chang YC, Oyama T, McGuire MJ, Brown KC. Cell-specific delivery of a chemotherapeutic to lung cancer cells. J Am Chem Soc. 2004;126:15656-15657. (Pubitemid 39602421)
15. 6 as a prognostic biomarker for nonsmall cell lung cancer. Cancer Res. 2007;67:5889-5895.
16. 3 expressed on both tumor cells and neovasculature. Bioconjug Chem. 2010;21:548-555.
17. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma. Mol Pharm. 2012;9:1409-1417.
18. + cancer stem cells in human liver cancer. Cancer Cell. 2008;13:153-166.
19. Liu Z, Jin C, Yu Z, et al. Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody. Bioconjug Chem. 2010;21:314-318.
20. 6 inhibits tumor progression in vivo by a transforming growth factor-betaregulated mechanism. Cancer Res. 2008;68:561-570.
21. Kraft S, Diefenbach B, Mehta R, Jonczyk A, Luckenbach GA, Goodman SL. Definition of an unexpected ligand recognition motif for avb6 integrin. J Biol Chem. 1999;274:1979-1985.
22. Nothelfer EM, Zitzmann-Kolbe S, Garcia-Boy R, et al. Identification and characterization of a peptide with affinity to head and neck cancer. J Nucl Med. 2009;50:426-434.
23. 6. J Pathol. 2010;222:52-63.
24. 2 with favorable properties for SPECT imaging of colon cancer. Bioconjug Chem. 2008;19:1170-1178.
25. Harris TD, Sworin M, Williams N, et al. Synthesis of stable hydrazones of a hydrazinonicotinyl-modified peptide for the preparation of 99mTc-labeled radio-pharmaceuticals. Bioconjug Chem. 1999;10:808-814. (Pubitemid 29456368)
26. Yamada H, Hirano S, Tanaka E, Shichinohe T, Kondo S. Surgical treatment of liver metastases from pancreatic cancer. HPB (Oxford). 2006;8:85-88.
27. Ouyang H, Wang P, Meng Z, et al. Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine. Pancreas. 2011;40:120-125.
28. 3 targeted radiotracers for tumor imaging. Mol Pharm. 2006;3:472-487.